Table 1. Patient Demographic and Clinical Characteristics of 24 Women With Newly Diagnosed Ovarian Cancer.
| Characteristic | No. (%) | P Value | ||
|---|---|---|---|---|
| Overall | Low Stroma (<50%) | High Stroma (≥50%) | ||
| No. | 24 | 15 | 9 | |
| Age, mean (SD), y | 62.0 (8.1) | 60.9 (8.8) | 63.9 (6.7) | .37 |
| Neoadjuvant chemotherapy | .06 | |||
| No | 17 (70.8) | 13 (86.7) | 4 (44.4) | |
| Yes | 7 (29.2) | 2 (13.3) | 5 (55.6) | |
| Ovarian cancer type | .27 | |||
| High-grade epithelial | 21 (87.5) | 12 (80.0) | 9 (100.0) | |
| Low-grade epithelial | 3 (12.5) | 3 (20.0) | 0 (0.0) | |
| Tumor grade | .42 | |||
| G1 | 2 (9.1) | 2 (15.4) | 0 (0.0) | |
| G2 | 5 (22.7) | 2 (15.4) | 3 (33.3) | |
| G3 | 15 (68.2) | 9 (69.2) | 6 (66.7) | |
| Stage | .61 | |||
| I-II | 5 (20.8) | 4 (26.7) | 1 (11.1) | |
| III-IV | 19 (79.2) | 11 (73.3) | 8 (88.9) | |
| Baseline CA-125, median (range), U/mL | 416 (32-2782) | 741 (32-2782) | 396 (88-2336) | .45 |
Abbreviation: CA 125, cancer antigen 125.